2,3-dibenzylbutane-1,4-diol has been researched along with fluorouracil in 1 studies
Studies (2,3-dibenzylbutane-1,4-diol) | Trials (2,3-dibenzylbutane-1,4-diol) | Recent Studies (post-2010) (2,3-dibenzylbutane-1,4-diol) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
---|---|---|---|---|---|
8 | 0 | 0 | 45,562 | 9,307 | 14,663 |
Protein | Taxonomy | 2,3-dibenzylbutane-1,4-diol (IC50) | fluorouracil (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
Aromatase | Homo sapiens (human) | 0.63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuoka, K; Hirano, T; Hosaka, K; Matsumoto, Y; Mitsuhashi, H; Naito, T; Oka, K | 1 |
1 other study(ies) available for 2,3-dibenzylbutane-1,4-diol and fluorouracil
Article | Year |
---|---|
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1.
Topics: 4-Butyrolactone; Adenosine Triphosphatases; Animals; Benzyl Compounds; Breast Neoplasms; Butylene Glycols; Cell Division; Cell Line; Dogs; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney Cortex; Lethal Dose 50; Lignans; Ouabain | 1990 |